A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. (Q40802872)

23 September 2017

A rapid assay for evaluation of antiviral activity against coxsackie virus B3, influenza virus A, and herpes simplex virus type 1. (English)

1 reference

23 September 2017

Schmidtke M

1

1 reference

23 September 2017

Schnittler U

2

1 reference

23 September 2017

Jahn B

3

1 reference

23 September 2017

Dahse H

4

1 reference

23 September 2017

Stelzner A

5

1 reference

23 September 2017

1 June 2001

1 reference

Journal of Virological Methods

23 September 2017

1 reference

23 September 2017

95

1 reference

23 September 2017

1-2

1 reference

23 September 2017

133-143

1 reference

A high throughput colorimetric cell proliferation assay for the identification of human cytomegalovirus inhibitors

23 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Picornavirus inhibitors

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Inhibition of the enteroviruses that cause acute hemorrhagic conjunctivitis (AHC) by benzimidazoles; enviroxime (LY 122772) and enviradone (LY 127123).

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Standardisation of a microplate in situ ELISA (MISE-test) for the susceptibility testing of herpes simplex virus to acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

A colorimetric assay for the measurement of the sensitivity of herpes simplex viruses to antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Antiviral drug susceptibility assays: going with the flow

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Current research on influenza and other respiratory viruses: II international symposium

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Optimization of in situ cellular ELISA performed on influenza A virus-infected monolayers for screening of antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Rapid and automated tetrazolium-based colorimetric assay for the detection of anti-HIV compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Flow cytometric analysis of herpes simplex virus type 1 susceptibility to acyclovir, ganciclovir, and foscarnet.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Rapid herpes simplex virus susceptibility testing using an enzyme-linked immunosorbent assay performed in situ on fixed virus-infected monolayers

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Comparison of RNA hybridization, hemagglutination assay, titration of infectious virus and immunofluorescence as methods for monitoring influenza virus replication in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Convenient assay for interferons

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Comparative evaluation of microplate enzyme-linked immunosorbent assay versus plaque reduction assay for antiviral susceptibility testing of herpes simplex virus isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

A comparative evaluation of three methods of antiviral susceptibility testing of clinical herpes simplex virus isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Characterization of the DNA polymerase and thymidine kinase genesof herpes simplex virus isolates from AIDS patients in whom acyclovirand foscarnet therapy sequentially failed

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Viral myocarditis: a paradigm for understanding the pathogenesis and treatment of dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Comparison of a DNA probe assay with the plaque reduction assay for measuring the sensitivity of herpes simplex virus and varicella-zoster virus to penciclovir and acyclovir

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

Flow cytometric analysis of vims-infected cells and its potential use for screening antiviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

An application of tetrazolium (MTT) colorimetric assay for the screening of anti-herpes simplex virus compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

MTT colorimetric assay system for the screening of anti-orthomyxo- and anti-paramyxoviral agents

1 reference

https://api.crossref.org/works/10.1016%2FS0166-0934%2801%2900305-6

7 January 2021

10.1016/S0166-0934(01)00305-6

Identifiers

DOI

1 reference

23 September 2017

1 reference